Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Adacel, Boostrix, Daptacel, Diphtheria and Tetanus Toxoids Adsorbed, Infanrix, Kinrix, Pediarix, Pentacel, Quadracel, Td Adsorbed, Tdvax, Tenivac, Vaxelis
Generic Name
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
DrugBank Accession Number
DB10584
Background

Not Available

Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Vaccines
Inactivated
Synonyms
  • Diphtheria toxoid
  • Diphtheria toxoid adsorbed

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to preventDiphtheriaCombination Product in combination with: Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)•••••••••••••••••••••
Used in combination to preventTetanusCombination Product in combination with: Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)•••••••••••••••••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbataceptThe therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Abatacept.
AdalimumabThe therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.
AldesleukinThe therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.
AlefaceptThe therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Alefacept.
AlemtuzumabThe therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Alemtuzumab.
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Diphtheria ToxoidLiquid50 lf / mLSubcutaneousAventis Pasteur Limited1925-12-312001-07-19Canada flag
Diphtheria Toxoid for Reaction Test 0.2lf/mlLiquid0.2 lf / mLIntradermalAventis Pasteur Limited1955-01-012000-04-06Canada flag
Diphtheria Toxoid for Schick Control 0.2lf/mlLiquid0.2 lf / mLIntradermalConnaught Laboratories Ltd.1925-12-311996-09-10Canada flag
Diphtheria Toxoid Immunization Of ReactorsLiquid4 lf / mLSubcutaneousAventis Pasteur Limited1933-12-312001-07-19Canada flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
AdacelCorynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 lf / 0.5 mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 mcg / 0.5 mL) + Bordetella pertussis fimbriae 2/3 antigen (5 mcg / 0.5 mL) + Bordetella pertussis pertactin antigen (3 mcg / 0.5 mL) + Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (2.5 mcg / 0.5 mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 lf / 0.5 mL)SuspensionIntramuscularSanofi Pasteur Limited1999-06-23Not applicableCanada flag
ADACELCorynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 Lf/0.5ml) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 mcg/0.5ml) + Bordetella pertussis pertactin antigen (formaldehyde inactivated) (3 mcg/0.5ml) + Bordetella pertussis toxoid antigen (formaldehyde inactivated) (2.5 mcg/0.5ml) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (1.5 mg/0.5ml)Injectionบริษัท ซาโนฟี่ ปาสเตอร์2012-06-27Not applicableThailand flag
ADACEL 0,5 ML IM ENJEKSİYONLUK SÜSPANSİYON İÇEREN FLAKON, 1 ADETCorynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 Lf/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 mcg/0.5mL) + Bordetella pertussis fimbriae 2/3 antigen (5 mcg/0.5mL) + Bordetella pertussis pertactin antigen (3 mcg/0.5mL) + Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (2.5 mcg/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 Lf/0.5mL)Injection, solutionIntramuscularSANOFİ PASTEUR AŞI TİC. A.Ş.2017-08-17Not applicableTurkey flag
ADACEL 0,5 ML IM ENJEKSİYONLUK SÜSPANSİYON İÇEREN FLAKON, 5 ADETCorynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 Lf/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 mcg/0.5mL) + Bordetella pertussis fimbriae 2/3 antigen (5 mcg/0.5mL) + Bordetella pertussis pertactin antigen (3 mcg/0.5mL) + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (2.5 mcg/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 Lf/0.5mL)Injection, solutionIntramuscularSANOFİ PASTEUR AŞI TİC. A.Ş.2017-08-17Not applicableTurkey flag
ADACEL POLIO 0,5 ML IM ENJEKSİYON İÇİN SÜSPANSİYON İÇEREN KULLANIMA HAZIR ENJEKTÖR, 1 ADETCorynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 Lf/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 mcg/0.5mL) + Bordetella pertussis fimbriae 2/3 antigen (5 mcg/0.5mL) + Bordetella pertussis pertactin antigen (3 mcg/0.5mL) + Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (2.5 mcg/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 Lf/0.5mL) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 DU/5mL) + Poliovirus type 2 antigen (formaldehyde inactivated) (8 DU/5mL) + Poliovirus type 3 antigen (formaldehyde inactivated) (32 DU/5mL)Injection, suspensionIntramuscularSANOFİ PASTEUR AŞI TİC. A.Ş.2008-12-302022-08-23Turkey flag

Categories

ATC Codes
J07AF01 — Diphtheria toxoid
Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
IRH51QN26H
CAS number
308079-75-6

References

General References
Not Available
RxNav
235600

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Active Not RecruitingOtherCoronavirus Disease 2019 (COVID‑19) / Rheumatic Diseases1
4Active Not RecruitingPreventionCervical Carcinoma / Human Papillomavirus (HPV) Infections1
4Active Not RecruitingPreventionPertussis1
4Active Not RecruitingTreatmentDTaP Vaccine1
4CompletedNot AvailableMultiple Sclerosis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection
SuspensionIntramuscular
Injection, suspensionIntramuscular
LiquidIntramuscular
LiquidSubcutaneous50 lf / mL
LiquidIntradermal0.2 lf / mL
LiquidSubcutaneous4 lf / mL
Injection, suspensionParenteral
Injection, powder, for suspensionIntramuscular
SolutionIntramuscular
Injection; injection, suspension; kitIntramuscular
Injection, solutionIntramuscular
Injection, suspensionIntramuscular30 iu/0.5ml
Injection, suspensionIntramuscular; Subcutaneous
InjectionIntramuscular30 iu/0.5ml
InjectionIntramuscular
Injection, suspension
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:04 / Updated at June 18, 2024 20:06